IGLON5 and glycogen storage disease VI: This contrasts against postmortem pathology-mapping, which is largely based on end-stage pathology such as neuronal loss; partial overlap with the regions of interest identified by murine modelling of IgLON5 expression is noted and may explain at least part of the regional vulnerability observed in IgLON5-IgG disease [1,14,15].